Slow Walking Speed May Signal Onset of Alzheimer's
the Psychiatry Advisor take:
The gait of an older adult may be an indicator of whether or not they develop Alzheimer’s disease later on.
Natalia del Campo, PhD, of Gerontopole and the Center of Excellence in Neurodegeneration of Toulouse, France, and colleagues examined 128 people, average age of 76 years old, without dementia but considered at high risk for it due to memory problems. Positron emission tomography scans were conducted on their brains, and 48% of participants had level of beta-amyloid at levels high enough to be associated with dementia.
Researchers also tested the subjects’ thinking and memory skills, as well as their ability to complete everyday tasks. Mild cognitive impairment was found in 46% of them.
The participants’ walking speed was also measured. There was a link between slow walking and speed and amyloid levels in certain areas of the brain, including one responsible for motor functions, the researchers reported in the journal Neurology.
After comparing the speed people walked with and without accounting for amyloid amounts, the researchers found up to 9% of the difference were the result of amyloid levels. However, the connection between amyloid and walking speed was not altered when accounting for age, education, or extent of memory problems.
“It’s possible that having subtle walking disturbances in addition to memory concerns may signal Alzheimer's disease, even before people show any clinical symptoms,” del Campo said in a statement.
Researchers found a link between slow walking and speed and amyloid levels in certain areas of the brain.
The speed at which elderly people walk may indicate their likelihood of developing Alzheimer's disease, according to research published in Neurology.
Researchers led by Natalia del Campo, PhD, of the Gerontopole and the Center of Excellence in Neurodegeneration of Toulouse, in France, hypothesized that a slower speed of walking may be related to the amount of amyloid plaque people with Alzheimer's have built up in their brains, even if they do not yet have external symptoms of Alzheimer's disease.
Amyloid precursor protein (APP) occurs throughout the body. The amyloid hypothesis proposes that there is a fault with the processing of APP in the brain, leading to the production of a short fragment of APP, a sticky protein known as beta-amyloid.
Psychiatry Advisor Articles
- Illicit Cannabis Use Among Adults Up Due to Medical Marijuana Laws
- Transcranial Direct Current Stimulation Inferior to Escitalopram
- Memory Training Opportunities Exist for Patients With Schizophrenia
- Early Detection Markers of Alzheimer's Disease Possibly Identified
- APA: Medical Discrimination Based on Size Psychologically, Physically Harms Patients
- Criteria For Identification of Smartphone Addiction
- Bipolar Disorder: Childhood Trauma Modulates Impact on Amygdala, Hippocampus
- Psychiatric Evaluations: Questions on Suicide Need to Be Rephrased
- Subsequent Suicide Attempts May Be Reduced by Emergency Department Interventions
- Most Opioids Prescribed for Patients With Mental Health Disorders
- Prescription Opioid Misuse Remains a Persistent Problem
- Revised Treatment Guidelines for Pediatric Acute Onset Neuropsychiatric Syndrome
- Long-term Response to Prophylactic Mood Stabilizers in Bipolar Disorder
- Medically Supervised Withdrawal, an Option for Pregnant Women Addicted to Opioids
- Navigating the Thin Line Between Identification & Intimacy With Patients